"Peritoneal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PERITONEUM.
| Descriptor ID |
D010534
|
| MeSH Number(s) |
C04.588.033.513 C04.588.274.780 C06.301.780 C06.844.620
|
| Concept/Terms |
Peritoneal Surface Malignancy- Peritoneal Surface Malignancy
- Malignancy, Peritoneal Surface
- Peritoneal Surface Malignancies
- Surface Malignancy, Peritoneal
- Peritoneal Carcinomatosis
- Carcinomatosis, Peritoneal
- Peritoneal Carcinomatoses
|
Below are MeSH descriptors whose meaning is more general than "Peritoneal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Peritoneal Neoplasms".
This graph shows the total number of publications written about "Peritoneal Neoplasms" by people in this website by year, and whether "Peritoneal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2001 | 4 | 0 | 4 |
| 2002 | 2 | 0 | 2 |
| 2003 | 0 | 1 | 1 |
| 2005 | 3 | 1 | 4 |
| 2006 | 3 | 2 | 5 |
| 2007 | 2 | 0 | 2 |
| 2008 | 3 | 1 | 4 |
| 2009 | 4 | 2 | 6 |
| 2010 | 2 | 0 | 2 |
| 2011 | 5 | 0 | 5 |
| 2012 | 4 | 2 | 6 |
| 2013 | 4 | 2 | 6 |
| 2014 | 1 | 0 | 1 |
| 2015 | 4 | 0 | 4 |
| 2016 | 5 | 1 | 6 |
| 2017 | 3 | 0 | 3 |
| 2018 | 4 | 0 | 4 |
| 2019 | 4 | 0 | 4 |
| 2020 | 5 | 0 | 5 |
| 2021 | 3 | 0 | 3 |
| 2022 | 6 | 0 | 6 |
| 2023 | 11 | 0 | 11 |
| 2024 | 6 | 1 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peritoneal Neoplasms" by people in Profiles.
-
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024. J Natl Compr Canc Netw. 2024 10; 22(8):512-519.
-
Mutational Features and Tumor Microenvironment Alterations in High-Grade Appendiceal Cancers Treated With Iterative Hyperthermic Intraperitoneal Chemotherapy. JCO Precis Oncol. 2024 Sep; 8:e2400149.
-
Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid. Oncogene. 2024 Jun; 43(24):1877-1882.
-
ASO Author Reflections: Venous Thromboembolism in Peritoneal Mesothelioma. Ann Surg Oncol. 2024 Jun; 31(6):3785-3786.
-
Utility of Circulating Tumor DNA Assessment in Characterizing Recurrence Sites after Optimal Resection for Metastatic Colorectal Cancer. J Am Coll Surg. 2024 Jun 01; 238(6):1013-1020.
-
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy postoperative symptomatology: palliative care impact. BMJ Support Palliat Care. 2024 Jan 08; 13(e3):e872-e875.
-
ASO Visual Abstract: Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery. Ann Surg Oncol. 2024 01; 31(1):657-658.
-
Mesothelioma in situ of the peritoneum: report of three cases and review of the literature. Histopathology. 2024 Feb; 84(3):492-506.
-
ASO Author Reflections: Fragmented Care in Patients with Peritoneal Metastases. Ann Surg Oncol. 2024 01; 31(1):655-656.
-
Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery. Ann Surg Oncol. 2024 Jan; 31(1):645-654.